Sage Therapeutics to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023, at 11:20 a.m. PT in Dana Point, CA.
A live webcast of the presentation can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230531005944/en/
Investor Contact
Ashley Kaplowitz
786-252-1419
[email protected]
Media Contact
Matthew Henson
917-930-7147
[email protected]
KEYWORDS: United States North America Massachusetts
INDUSTRY KEYWORDS: Mental Health Health Neurology Other Health Pharmaceutical Biotechnology
MEDIA:
| Logo |
 |